Naoko Unami

Discovery of a novel series of biphenyl benzoic acid derivatives as potent and selective human beta3-adrenergic receptor agonists with good oral bioavailability. Part I.

M. Sakurai, Y. Matsumura, M. Imanishi, 2008, Journal of medicinal chemistry.

Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human beta(3)-adrenergic receptor agonists: Part IV.

Nobuhiro Yamamoto, Minoru Sakurai, Yutaka Nakajima, 2008, Bioorganic & medicinal chemistry letters.

Discovery of highly potent and selective biphenylacylsulfonamide-based beta3-adrenergic receptor agonists and evaluation of physical properties as potential overactive bladder therapies: part 5.

M. Sakurai, Y. Matsumura, M. Imanishi, 2009, Journal of medicinal chemistry.

Discovery of a novel series of benzoic acid derivatives as potent and selective human beta3 adrenergic receptor agonists with good oral bioavailability. 3. Phenylethanolaminotetraline (PEAT) skeleton containing biphenyl or biphenyl ether moiety.

M. Sakurai, Y. Matsumura, M. Imanishi, 2008, Journal of medicinal chemistry.

Discovery of a novel series of biphenyl benzoic acid derivatives as highly potent and selective human beta3 adrenergic receptor agonists with good oral bioavailability. Part II.

M. Sakurai, Y. Matsumura, M. Imanishi, 2008, Journal of medicinal chemistry.

Anticoagulant activity of apixaban can be estimated by multiple regression analysis

Hidenori Suzuki, Naoko Unami, Y. Ise, 2020, Journal of arrhythmia.

Predicting the Anticoagulant Activity of Apixaban from Prothrombin Time of Warfarin when Replacing Warfarin with Apixaban

Naoko Unami, Shirou Katayama, 2016 .